RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,553,131 | +48.7% | 153,618 | +67.4% | 0.00% | +50.0% |
Q2 2023 | $1,716,417 | +0.1% | 91,787 | -1.8% | 0.00% | 0.0% |
Q1 2023 | $1,715,505 | -7.3% | 93,488 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,851,062 | -19.5% | 93,488 | -3.0% | 0.00% | -33.3% |
Q3 2022 | $2,299,000 | +30.8% | 96,333 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $1,758,000 | -18.5% | 96,333 | -1.7% | 0.00% | 0.0% |
Q1 2022 | $2,156,000 | -45.9% | 98,045 | -9.7% | 0.00% | -33.3% |
Q4 2021 | $3,987,000 | +53.5% | 108,543 | +29.8% | 0.00% | 0.0% |
Q3 2021 | $2,597,000 | +8.8% | 83,640 | +7.5% | 0.00% | +50.0% |
Q2 2021 | $2,387,000 | +66.1% | 77,840 | +20.3% | 0.00% | 0.0% |
Q1 2021 | $1,437,000 | +19.0% | 64,719 | +5.8% | 0.00% | +100.0% |
Q4 2020 | $1,208,000 | -35.3% | 61,162 | +5.5% | 0.00% | -66.7% |
Q3 2020 | $1,867,000 | +140.3% | 57,970 | +116.5% | 0.00% | +200.0% |
Q2 2020 | $777,000 | +132.6% | 26,770 | +70.5% | 0.00% | 0.0% |
Q1 2020 | $334,000 | -6.2% | 15,698 | +21.8% | 0.00% | 0.0% |
Q4 2019 | $356,000 | – | 12,888 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |